NCT00646321View on ClinicalTrials.gov

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

PHASE3CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

August 31, 2004

Conditions
Asthma
Interventions
DRUG

budesonide/formoterol (Symbicort)

DRUG

budesonide

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY